However, nuclear PD-L1 compartmentalization elicited stronger antitumor immunity and antitumor effect than PD-L1 deletion (Figure 2), indicating that nPD-L1 may overcome resistance of tumor cells to PD-L1 loss. The gene discussed is CD274; the disease is neoplasm.